For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250409:nRSI3896Ea&default-theme=true
RNS Number : 3896E Induction Healthcare Group PLC 09 April 2025
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Board Changes
Induction Healthcare (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide announces that Andy Williams
has submitted his resignation to the Board, stepping down from his position as
Non-Executive Director and member of the Audit, Remuneration, and Nomination
Committees of the Board with immediate effect.
The Board would like to take this opportunity to thank Andy for his
contribution to the Company and wish him well for the future.
ENQUIRIES
Induction Healthcare Group
Christopher Samler, Chair +44 (0)7712 194092
Paul Tambeau, Chief Executive Officer +44 (0)7983 104443
Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000
Philip Davies
Oliver Platts
About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)
Induction (AIM: INHC) delivers a suite of software solutions through a single
integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.
Used at scale by national and regional healthcare systems, as well as
non-health government services, our applications are relied upon by hundreds
of thousands of clinicians and millions of patients across almost every
hospital in the British Isles.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAUPUCPCUPAGQB